Media

Support Of Industry Underscores Pro-Business Commitment
Washington, D.C. (September 22, 2014) – BIO President and CEO James Greenwood joined AdvaMed President and CEO Stephen Ubl and PhRMA President and CEO...

Press Releases

Apr 26 2000
WASHINGTON, D.C. (April 26, 2000) Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement in response to...
Apr 14 2000
WASHINGTON, D.C. (April 14, 2000) The BiotechnologyIndustry Organization (BIO) has put together a coalition of entrepreneurial associations to support full...
Apr 13 2000
WASHINGTON (APRIL 13, 2000)-- We commend the work of the House subcommittee report which encompasses the research and testimony of distinguished scientists who...
Apr 12 2000
WASHINGTON, D.C., (April 12, 2000) Nancy Bradish Myers, health-care policy and reimbursement counsel for the Biotechnology Industry Organization (BIO), issued...
Apr 5 2000
(Dr. Val Giddings, vice president for food and agriculture of the Biotechnology Industry Organization (BIO) today made the following comments in response to...
Apr 5 2000
WASHINGTON (April 5, 2000) Recommendations put forth today in a National Research Council report entitled Genetically Modified Pest Protected Plants: Science...
Apr 5 2000
WASHINGTON, D.C. (April 5, 2000) The Biotechnology Industry Organization (BIO) applauded President Clinton for comments today clarifying his March 14 joint...
Apr 4 2000
WASHINGTON (April 3, 2000) The Biotechnology Industry Organization (BIO) today announced as chairman of the board of directors, Mark Skaletsky, president and...
Apr 4 2000
(Carl B. Feldbaum, president of BIO, today issued the following statement regarding a request by Reps. Dennis Kucinich (D-Ohio) and Jack Metcalf (R-Wash.) to...


Biotechnology News

October 21, 2014

PLEASANTON, Calif. & PRINCETON, N.J.--(BUSINESS WIRE)--inVentiv Health Clinical, a leading global supplier of drug development services, will replace its electronic...

October 21, 2014

HYDERABAD, India--(BUSINESS WIRE)--GVK BIO Announces Successful Completion of Drug Repurposing Efforts to Identify Novel Indications

October 21, 2014

NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (Nasdaq: KMDA) (TASE: KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces that a...

October 21, 2014

RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) announced today that Dr. Anthony Lembo of Beth Israel Deaconess Medical Center will present the...

October 21, 2014

MODI’IN, Israel--(BUSINESS WIRE)--Exalenz Bioscience (TASE:EXEN), a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range...